Sat.Jun 20, 2020 - Fri.Jun 26, 2020

article thumbnail

Lab Manager Ask the Expert

Drug Patent Watch

Check out the latest issue of Lab Manager where I discuss my interest in informatics, the complexities of informatics for today’s scientists, and some of the tools available. [link]. The post Lab Manager Ask the Expert appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Accelerating your digital IQ for the next normal of customer engagement

pharmaphorum

COVID-19 has brought many changes to the pharmaceutical industry, among them a need to change how pharma companies engage with HCPs and transform their approach to digital channels. This webinar, held in association with Veeva, will present some exclusive market observations from before and during the COVID crisis and explain how pharmaceutical companies can increase their digital IQ and accelerate the move to digital.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Drug Channels News Roundup, June 2020: CVS’s New GPO, CMS on Copay Accumulators, GoodRx Fees, Supermarket Pharmacies, and Merck’s Ken Frazier

Drug Channels

Happy 244th birthday, America! Before you declare your (socially-distanced) independence, get up close and personal with these Drug Channels fireworks: CVS launches a new GPO for its PBM CMS rethinks copay accumulators Here’s how GoodRx makes money Supermarkets face pharmacy challenges Plus, powerful and important comments from Ken Frazier, CEO of Merck.

article thumbnail

Pandemic Gives a Glimpse of Life With a Disability

ComputerTalk

Ordinary life just got more complicated for us all.

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

DrugPatentWatch and Bloomberg: Are there too many generic patent challenges?

Drug Patent Watch

Check out this Bloomberg Law article where DrugPatentWatch shows how the number of patent challenges is increasing, while the number of challengers of each patent is also increasing. Why might this…. The post DrugPatentWatch and Bloomberg: Are there too many generic patent challenges? appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Unlocking health data to improve oncology outcomes

pharmaphorum

As use of real-world evidence increases there is an opportunity to improve the patient experience. In addition to key steps forward with the establishment of Health Data Research UK and NHSX, information governance will be key, as is alignment to UK and EU regulations such as the July 2019 DHSC Framework for the Value of NHS Research and GDPR.

52

More Trending

article thumbnail

Codeine – It’s Complicated

Med Ed 101

I received a question about codeine and what to expect from its use. When I was first learning pharmacy back in the late 2000s, I saw a lot of codeine. Most frequently, I remember significant use of Tylenol #3. Thankfully, I don’t see it used very often anymore. Why do I say “thankfully”? Codeine kinetics […]. The post Codeine – It’s Complicated appeared first on Med Ed 101.

40
article thumbnail

Federal Courts begin to phase out the Suspension Period

Pharma in Brief

On June 11, 2020 the Federal Court ( FC ) and Federal Court of Appeal ( FCA ) published updated notices to gradually phase out the Suspension Period, which had previously been extended to June 15, 2020. Federal Court. The FC’s June 11, 2020 Practice Direction and Order ( Updated Order ), amends its previous Practice Directions, which, subject to the amendments listed, continue to remain in force.

article thumbnail

Helping The Vocally Impaired Speak in Their Own Voice

ComputerTalk

Thanks to voice banking, digitized speech retains the essence of the original speaker.

40
article thumbnail

Episode 515: IV Push Piperacillin/Tazobactam

Pharmacy Joe

In this episode, I’ll discuss an article about IV push piperacillin-tazobactam. Episode 515: IV Push Piperacillin/Tazobactam Subscribe on iTunes , Android , or Stitcher Article Safety and tolerability of i.v. push piperacillin/tazobactam within an emergency department Lead author: William Blake Hays Published in American Journal of Health-System Pharmacy May 2020 Background Piperacillin/tazobactam is typically administered via IV piggyback over 30 minutes or more increasingly common via extended

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Can I Take Sulfonylureas With a Sulfa Allergy

Med Ed 101

Many patients are labeled as having a “sulfa allergy”. This is typically going to be from a reaction to sulfa antibiotics (i.e. sulfamethoxazole). Sulfonylureas are one of the drug classes that have sulfonamides as part of their chemical structure so therefore a theoretical cross-reactivity is possible. An estimated 3 – 6% of the population are […].

article thumbnail

PMPRB launches consultation on revised Draft Guidelines

Pharma in Brief

On June 19, 2020, the Patented Medicine Prices Review Board ( PMPRB ) launched its consultation on revised Draft Guidelines to implement the amended Patented Medicines Regulations. The revised Guidelines outline new price tests for existing and new patented medicines, as well as a revised risk-based system for reporting and investigations. They will be available for public comment until July 20, 2020.